Evidence map›Paper›PMID 41378204›Full record

ArticleFrontiers in pharmacology2025

ER stress in D1-MSNs mediates cocaine-induced behavioral plasticity

Yue Zhao, Shu Li, Linhong Jiang, Ying Zhao, Weihong Kuang, Qingfan Wei, Yuanyi Zhou, Shuang Han, Liang Wang, Hongchun Li and 13 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yue Zhao *Mental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Shu Li *Mental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Linhong JiangMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Ying ZhaoDepartment of Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Weihong KuangMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Qingfan WeiMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yuanyi ZhouMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Shuang HanMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Liang WangMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Hongchun LiMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yanping DaiMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Xiaofeng YangMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Siqi XuMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Feng QinMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Rong ChenMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yaxing ChenMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Chunqi LiuMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Qian BuChengdu Westchina Frontier Pharmatech, Co., Ltd., Chengdu, China.
Bo ChenChengdu Westchina Frontier Pharmatech, Co., Ltd., Chengdu, China.
Bin LiuChengdu Westchina Frontier Pharmatech, Co., Ltd., Chengdu, China.
Meng QinMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yinglan ZhaoMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Xiaobo CenMental Health Center and Center for Preclinical Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cocaine-induced endoplasmic reticulum (ER) stress has been increasingly recognized, but its neuronal specificity and functional significance remain unclear. Because the ER is also a major site for lipid and sphingolipid biosynthesis, cocaine-triggered ER stress may influence metabolic pathways linked to cellular stress signaling. Here, we sought to define the cell-type specificity and downstream consequences of cocaine-induced ER stress in the nucleus accumbens (NAc). Methods: We combined cocaine administration with ultrastructural analysis of ER morphology, immunohistochemical and molecular profiling of ER stress pathways, and assays of sphingolipid biosynthesis in the NAc. We also evaluated the effects of pharmacological inhibition of ER stress and sphingolipid synthesis, and performed D1-MSN-specific knockdown of Results: Cocaine selectively activated ER stress in dopamine receptor 1 (D1)-expressing medium spiny neurons (MSNs), marked by induction of activating transcription factor 4 (ATF4). Cocaine also upregulated serine palmitoyltransferase long-chain base subunit 1 (SPTLC1), and promoter analysis with functional validation identified Discussion: These findings identify a D1-MSN ER stress response that promotes cocaine-induced neuroadaptations via the ATF4-SPTLC1 signaling axis and suggest a potential therapeutic target for cocaine addiction.

Indexed as

cocaineD1-type medium spiny neuronsendoplasmic reticulum stresssphingolipid metabolismSPTLC1

Identifiers

PMID41378204
PMCPMC12685851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.